Replies to post #15731 on Mymetics Corp (MYMX)

[TheHungryHippo]

We got three things here I am waiting to see near term that may possibly be a big positive boost to the perception of this stock. There are other things but, these I really want to see what happens ...


1. An update on Cancer immunotherapy with EtheRNA out of Belgium for RNA vaccines:

https://www.etherna.be/newsroom/news/155-mymetics-starts-research-collaboration-project-in-cancer-immunotherapy-with-etherna


2. A possibility of an exclusive worldwide license agreement with Anergis SA for Allergy Vaccines,
Which now has involved: Billionaire "Ernesto Bertarelli" w/ Waypoint Capitol and Stallergenes Greer:

https://www.biospace.com/article/releases/stallergenes-greer-and-anergis-initiate-new-study-to-predict-efficacy-of-second-generation-allergen-immunotherapy-/


3. An update on the Manufacturing Agreement with Upperton Ltd. out of the UK. I suspect there are near term revenues possible here:

On July 26, 2019 Mymetics and Upperton Ltd. signed a License Agreement (the “Agreement”) that sets out the rights and obligations of the two parties with respect to the development, manufacturing and exploitation of certain virus-like particles based vaccines (which includes virosomes) into solid (powder or tablet) form that are based on each party’s background or pre-existing intellectual property (“IP”) and the foreground IP rights or the IP that was developed by either party or both parties during the Maciviva project and could be developed during future collaborations.

Under the terms of the Agreement Mymetics receives an exclusive and royalty free, worldwide license to use the Upperton background IP for the development, research, sale or in/out license for virus-like particle vaccines that use the foreground IP rights. All title, right and interest in and to all foreground IP rights vests in Mymetics for such development, research, sale or in/out license, and Mymetics is free to use and exploit such foreground IP rights.